Mortality Due to COVID-19 in the COVID-AGEBRU Study
Study Details
Study Description
Brief Summary
The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations, the negative impact is higher in older people, pointing this population as the most severely affected.
The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19
Study Design
Outcome Measures
Primary Outcome Measures
- All-cause mortality during hospital admission (admission up to discharge time) [Through study completion, an average of one month.]
Vital status was obtained from medical records
Secondary Outcome Measures
- Prevalence of medical diseases and geriatric syndromes [Through study completion, an average of one month.]
Clinical and demographical conditions, and geriatric syndromes
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients aged 70 and older
-
Patients admitted to an acute care geriatric unit due to COVID-19
-
Patients with COVID-19 by PCR, serology or CT scan suggestive of this disease
Exclusion Criteria:
- No other demographic or clinical exclusion criteria will be applied
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU Brugmann | Brussels | Belgium | 1020 |
Sponsors and Collaborators
- Brugmann University Hospital
Investigators
- Principal Investigator: Murielle MS Surquin, MD PhD, CHU Brugmann, Director of the Geriatrics Department
Study Documents (Full-Text)
None provided.More Information
Publications
- Ménager P, Brière O, Gautier J, Riou J, Sacco G, Brangier A, Annweiler C, Geria-Covid Study Group OBOT. Regular Use of VKA Prior to COVID-19 Associated with Lower 7-Day Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Cohort Study. Nutrients. 2020 Dec 24;13(1). pii: E39. doi: 10.3390/nu13010039.
- Mendes A, Serratrice C, Herrmann FR, Genton L, Périvier S, Scheffler M, Fassier T, Huber P, Jacques MC, Prendki V, Roux X, Di Silvestro K, Trombert V, Harbarth S, Gold G, Graf CE, Zekry D. Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study. J Am Med Dir Assoc. 2020 Nov;21(11):1546-1554.e3. doi: 10.1016/j.jamda.2020.09.014. Epub 2020 Sep 15.
- Miralles O, Sanchez-Rodriguez D, Marco E, Annweiler C, Baztan A, Betancor É, Cambra A, Cesari M, Fontecha BJ, Gąsowski J, Gillain S, Hope S, Phillips K, Piotrowicz K, Piro N, Sacco G, Saporiti E, Surquin M, Vall-Llosera E. Unmet needs, health policies, and actions during the COVID-19 pandemic: a report from six European countries. Eur Geriatr Med. 2021 Feb;12(1):193-204. doi: 10.1007/s41999-020-00415-x. Epub 2020 Oct 15. Review. Erratum in: Eur Geriatr Med. 2021 Jun;12(3):667.
- COVID-19 AGE-BRUGMANN 2020/111